Back to Search
Start Over
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?
- Source :
-
Reviews in medical virology [Rev Med Virol] 2021 May; Vol. 31 (3), pp. e2172. Date of Electronic Publication: 2020 Sep 22. - Publication Year :
- 2021
-
Abstract
- Severe acute respiratory syndrome coronavirus-2 causes the clinical syndrome of coronavirus disease of 2019 (COVID-19) which has become a global pandemic resulting in significant morbidity and mortality. While the virus primarily affects the respiratory system, it also causes a wide variety of complex cardiac manifestations such as acute myopericarditis, acute coronary syndrome, congested heart failure, cardiogenic shock and cardiac arrhythmias. There are numerous proposed mechanisms of cardiac injury, including direct cellular injury, pro-inflammatory cytokine storm, myocardial oxygen-demand mismatch, and systemic inflammation causing multi-organ failure. Additionally, medications commonly used to treat COVID-19 patients have various cardiovascular side effects. We aim to provide a succinct review about the pathophysiology and cardiac manifestations of COVID-19, as well as treatment considerations and the various adaptations made to the current healthcare structure as a result of the pandemic.<br /> (© 2020 John Wiley & Sons Ltd.)
- Subjects :
- Acute Coronary Syndrome epidemiology
Acute Coronary Syndrome pathology
Acute Coronary Syndrome virology
Antiviral Agents administration & dosage
Antiviral Agents adverse effects
Arrhythmias, Cardiac epidemiology
Arrhythmias, Cardiac pathology
Arrhythmias, Cardiac virology
Biomarkers analysis
COVID-19 epidemiology
COVID-19 pathology
COVID-19 virology
Cardiac Catheterization methods
Comorbidity
Disease Management
Glucocorticoids administration & dosage
Glucocorticoids adverse effects
Heart Failure epidemiology
Heart Failure pathology
Heart Failure virology
Hospitalization
Humans
Immunologic Factors administration & dosage
Immunologic Factors adverse effects
Pericarditis epidemiology
Pericarditis pathology
Pericarditis virology
Risk Factors
SARS-CoV-2 pathogenicity
Severity of Illness Index
Shock, Cardiogenic epidemiology
Shock, Cardiogenic pathology
Shock, Cardiogenic virology
Texas epidemiology
Acute Coronary Syndrome therapy
Arrhythmias, Cardiac therapy
COVID-19 therapy
Heart Failure therapy
Pandemics
Pericarditis therapy
Shock, Cardiogenic therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1099-1654
- Volume :
- 31
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Reviews in medical virology
- Publication Type :
- Academic Journal
- Accession number :
- 32959951
- Full Text :
- https://doi.org/10.1002/rmv.2172